Welcome to the Burg Simpson website, please upgrade your Flash Plugin and enable JavaScript.

Home > Dangerous Drugs > Nephrogenic Systemic Fibrosis (NSF)

Gadolinium Dyes and Nephrogenic Systemic Fibrosis Claims Attorneys

In Ohio, Colorado and Nationwide

Gadolinium is a contrast agent that helps distinguish between normal and abnormal tissue in the body when used with magnetic resonance imaging (MRI) and/or CT scans. Gadolinium was approved for use in 1988.

"Gadolinium law suits picks up pace"
– Correy E. Stephenson, Missouri Lawyers Weekly

Click to read the report done by Dayle Cedars, News7, Denver, CO:
"MRI Contrast Can Cause Disease – Gadolinium Blamed For Problems"
or click to view the video

Click to read the report done by Mike TeSelle, KCRA 3, Sacramento, CA:
"Some Kidney Patients Suffer MRI Poisoning
– Dye Containing Gadolinium Blamed For Problems"

Click to view our video about "Gadolinium Dyes"

Click to view our video about "Nephrogenic Systemic Fibrosis"

View our NSF brochure for more information

Click to read the report done by Correy E. Stephenson, Lawyers USA:
"Gadolinium litigation heats up"

Nephrogenic systemic fibrosis (NSF), described in 2000, is an emerging systemic disorder characterized by widespread tissue fibrosis. NSF was not known to the medical community before March 1997 and some medical authors suggest that the sudden occurrence of the disease in the last 8 years makes it likely that a new agent or technique of examination causes it. Currently, there is no effective treatment available for NSF.

Based on recent research, NSF occurs only in patients with advanced or in end stage kidney disease and is strongly related to the use of gadolinium dyes for MRI scans. At this time, there are no known cases of NSF in patients with normal kidney function.

In a pivotal study in 2006 conducted by Dr. T. Grobner it was noted that 5 of their 9 patients diagnosed with NSF had received a MRI involving use of Omniscan Contrast Dye, a gadolinium-based contrast agent manufactured by GE. This study was followed shortly by other studies and case reports showing a similar strong association.

The Little-Known Debilitating and Deadly Danger of MRIs

Gadolinium and NSF/NFD

Preventing NSF/NFD

The Effects of NSF/NFD

Treating NSF/NFD

Gadolinium Manufacturers

Frequently Asked Questions About
Nephrogenic Systemic Fibrosis (NSF) Lawsuits

If you believe you have developed NSF, we strongly advise you to contact your physician for an examination which may involve a skin biopsy. If you are, in fact, diagnosed with NSF then you may want to talk with an attorney in order to protect your legal rights. Burg Simpson is here to help you. We take cases on a contingency basis, which means that we are paid only if we bring about a recovery for our clients. We have already retained national experts in assist us with your case. Contact us now to schedule your free confidential consultation with our experienced defective product attorneys.

For more information about this topic read "Gadolinium detected in NSF patients body tissues" written by John M. Restaino, Jr., DPM, J.D.

¹Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006 Apr;21(4):1104-8. (Grobner, 2006). Erratum 2006 Jun;21(6):1745.

Return to the Dangerous Drugs Section

Return to the Medical Devices Section

Return to the Dangerous Diseases Section

Colorado Wyoming Ohio Arizona

Gadolinium Dyes and Nephrogenic Systemic Fibrosis Claims Attorneys

In Ohio, Colorado and Nationwide

$5,350,000

$1,300,000

$690,000,000

$5,800,000